BHI Therapeutic Sciences Jamaica

Our Vision

“We foresee stem cell therapies becoming the preferred substitutes for many medical, surgical, pharmacological, and rehabilitative medical services.”

BHI Therapeutic Sciences Jamaica provides access to stem cell therapies to patients who may benefit from these treatments. We engage in collaborative relationships with leading institutions, scientists, and physicians across the globe.

We only utilize stem cells from either your own body (autologous) or from umbilical cord donors who have proceeded through a multiple step testing process that ensures stem cell patient safety. We do not use embryonic stem cells, nor will we ever.

BHI Therapeutic Sciences Jamaica has US board-certified physicians on staff for your safety. Our Scientific Advisory Board and Ethics Committee oversee the disease-specific protocols to ensure the highest standards of patient safety.

BHI Therapeutic Sciences Jamaica provides therapies for neurologic disorders, autoimmune diseases, and orthopedics conditions.

Hundreds of allogeneic stem cell therapies are underway in humans for a wide-range of medical conditions. However, some of these studies do not follow regulatory compliances and accordingly they have not been proven to be safe.   The human Umbilical Cord Blood products that have been evaluated in clinical studies conducted by BHITS were collected in accordance with Good Tissue Practice to ensure the safety of the administered cellular product. BHITS has unique advantages over its competitors. We are in regulatory compliance in each country we conduct clinical trials to ensure the lab and clinical procedures are lawfully approved by their federal agencies. Based on our nonclinical and pilot clinical study results, showing the safety of our human umbilical cord blood product, we are planning to start Investigational New Drug (IND) clinical trials. We are initiating an IND Phase 1 clinical trial of an FDA approved HCP, cord blood product for acute ischemic stroke indication. In specific markets around the world, there is both the unmet need and the financial opportunity to establish medical facilities that provide the same quality as that found in the best facilities in the United States. BHITS believes it is uniquely positioned to become a leader in providing the highest quality cellular therapies through centers it intends to locate throughout the world. BHITS has recruited top medical professionals and scientific advisors, and regulatory specialists to help determine the best possible procedures to offer, to provide the appropriate protocols to monitor safety and efficacy, to collect and analyze outcome data for potential submission to the FDA and EMA, and to innovate patent procedures, devices, and therapies for future commercialization.

Cellular medicine is in high demand and stem cells have the potential to treat a wide range of diseases. Stem cells are essentially “blank slate” cells that possess the remarkable potential to differentiate to any one of the billions of cells that form the diverse tissues of the human body. In addition, stem cells have the power to divide virtually without limits and convert or develop into specialized cells that can replace injured or damaged tissue.

Stem cell research is the most exciting option in the field of regenerative medicine being tested for efficacy in treating a variety of health issues where the body’s own response to traditional treatment isn’t sufficient to restore health and optimum function.

Patients with a variety of afflictions such as diabetes, autoimmune disorders, brain trauma, spinal cord injury, and neurologic disorders may benefit from these therapies. Our medical team is happy to discuss potential outcomes and answer any questions you may have.

BHI Therapeutic Sciences Jamaica has taken every precaution to ensure the safety and viability of administered stem cells. BHI Therapeutic Sciences stem cells are tested for sterility, infectious diseases and have high cell count and viability. Every unit of Human Umbilical Cord Blood Mononuclear Cells and Human Umbilical Cord Mesenchymal Stem Cells has the Cell Quality Certificate with the following information: Virus Tests (Hepatitis B virus, Hepatitis C virus, Human Immunodeficiency virus and Treponema pallidum), Microbiological Tests (Bacteria, Fungus, Mycoplasma, Endotoxin), the cell  count and viability.

Human Umbilical Cord Blood Mononuclear Cells

Human Umbilical Cord Mesenchymal Stem Cells

More and more patients are traveling abroad for medical treatments. As our organization continues to conduct research and collect data on the potential benefits of stem cells and we move toward FDA approval in the United States, Jamaica affords us the ability to provide these treatments now. Furthermore, Jamaica is the largest English-speaking Caribbean Island.

BHI Jamaica is located in Montego Bay.

The facility is designed to be a state-of-the-art, GMP-certified facility.

Patients can stay on site or in area luxury hotels.

Treatment costs vary, but are typically $5,000 per therapy